313 related articles for article (PubMed ID: 6765083)
1. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
Marconi P; Bistoni F
Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
[No Abstract] [Full Text] [Related]
2. [Antitumor immunoadjuvants of microbial origin: the limitations in the immune system and microbial structure].
Cassone A
Ann Ist Super Sanita; 1982; 18(3):497-500. PubMed ID: 6765082
[No Abstract] [Full Text] [Related]
3. Enhancement of host defense mechanisms by pharmacological agents.
Jordan GW; Merigan TC
Annu Rev Pharmacol; 1975; 15():157-75. PubMed ID: 1096788
[No Abstract] [Full Text] [Related]
4. Antitumor activity of Corynebacterium parvum.
Milas L; Scott MT
Adv Cancer Res; 1978; 26():257-306. PubMed ID: 343523
[No Abstract] [Full Text] [Related]
5. Effects of anticancer drugs on the immune system in humans.
Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
[No Abstract] [Full Text] [Related]
6. [Cancer and the lymphatic system].
Grekh IF
Vopr Onkol; 1971 Sep; 17(10):101-10. PubMed ID: 4947716
[No Abstract] [Full Text] [Related]
7. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
8. Immunomodulation in cancer therapeutics.
Ehrke MJ
Int Immunopharmacol; 2003 Aug; 3(8):1105-19. PubMed ID: 12860167
[TBL] [Abstract][Full Text] [Related]
9. Immunopotentiation of anticancer chemotherapy by Candida albicans, other yeasts and insoluble glucan in an experimental lymphoma model.
Cassone A; Bistoni F; Cenci E; Pesce CD; Tissi L; Marconi P
Sabouraudia; 1982 Jun; 20(2):115-25. PubMed ID: 7051368
[TBL] [Abstract][Full Text] [Related]
10. Complement function in mAb-mediated cancer immunotherapy.
Gelderman KA; Tomlinson S; Ross GD; Gorter A
Trends Immunol; 2004 Mar; 25(3):158-64. PubMed ID: 15036044
[No Abstract] [Full Text] [Related]
11. [Use of preparations of microbial origin for stimulating antitumor resistance].
Zatula DG; Zaval'niuk AK
Eksp Onkol; 1986; 8(6):3-9. PubMed ID: 3542497
[TBL] [Abstract][Full Text] [Related]
12. BCG in tumor immunotherapy.
Baldwin RW; Pimm MV
Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
[No Abstract] [Full Text] [Related]
13. [Immunostimulation].
Miescher PA
Verh Dtsch Ges Inn Med; 1978; (84):490-502. PubMed ID: 84450
[No Abstract] [Full Text] [Related]
14. On the immunopharmacology of cancer chemotherapeutics.
Spreafico F
Behring Inst Mitt; 1984 May; (74):230-8. PubMed ID: 6541034
[TBL] [Abstract][Full Text] [Related]
15. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
[TBL] [Abstract][Full Text] [Related]
16. [Immunomodulating properties of antitumor antibiotics].
Viadro MM
Antibiot Med Biotekhnol; 1987 Aug; 32(8):611-7. PubMed ID: 3314693
[No Abstract] [Full Text] [Related]
17. [A system of individual immunotherapy with leakadin in the combined therapy of acoustic neurinomas].
Starchenko AA; Khil'ko VA; Komarets SA; Khlunovskiĭ AN; Prilukova TI; Kraskovskaia SV; Danilov AV
Zh Vopr Neirokhir Im N N Burdenko; 1996; (4):15-8. PubMed ID: 9092246
[TBL] [Abstract][Full Text] [Related]
18. Antitumoral effects of lipid A: preclinical and clinical studies.
Pance A; Reisser D; Jeannin JF
J Investig Med; 2002 May; 50(3):173-8. PubMed ID: 12033281
[No Abstract] [Full Text] [Related]
19. The effects of a blockading agent on the primary immune response.
Michael JG; Murray C
J Immunol; 1970 Aug; 105(2):411-5. PubMed ID: 4914938
[No Abstract] [Full Text] [Related]
20. [Radiotherapy and antitumor immunity. Immunomodifying action of ionizing radiation].
Klimovich VB
Med Radiol (Mosk); 1983 Jul; 28(7):77-84. PubMed ID: 6224065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
